Telemedicine rules for opioid treatment delayed again, now until end of 2025
What happened
The US government has once again delayed new rules that would make it easier to prescribe buprenorphine, a medication for opioid addiction, through telemedicine. This means patients will have to wait longer to get this treatment remotely, especially veterans.
Why it matters
The US is in the middle of an opioid crisis, and buprenorphine is a key treatment. Telemedicine can make it much easier for people in rural areas or those with limited mobility to access care. Each delay means more people struggle to get treatment, and the existing rules, which require an in-person visit for the first prescription, remain in place.
The signal
Watch for any further delays or changes to the rules before December 31, 2025, as the government continues its review.